UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 201 - 250 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Maratona Urológica 2009 - Management of muscle invasive disease - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Transurethral resection alone can be effective in muscle invasive tumors.
Login to read more...

Maratona Urológica 2009 - Management of non-invasive bladder cancer in the elderly - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Bacillus Calmette-Guérin (BCG) is the gold standard for carcinoma in situ (CIS) and high-grade papillary tumors.
Login to read more...

Maratona Urológica 2009 - Radiotherapy for bladder cancer - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Tri-modality therapy of TURBT, radiation therapy, and chemotherapy is effective therapy for muscle invasive bladder cancer.
Login to read more...

Maratona Urológica 2009 - Bladder cancer in the elderly - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - A recent study from Vanderbilt University detailed the outcomes of 382 patients undergoing radical cystectomy of whom 44 were 75 years of age or older.
Login to read more...

Maratona Urológica 2009 - Treatment of muscle invasive bladder cancer in elderly - Slide Presentation
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by David P. Wood, MD at the VI Maratona Urológica do Rio de Janeiro - August 14 - 15, 2009.
Login to read more...

Maratona Urológica 2009 - Radical cystectomy technique and results - Slide Presentation
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by David P. Wood, MD at the VI Maratona Urológica do Rio de Janeiro - August 14 - 15, 2009.
Login to read more...

Maratona Urológica 2009 - Early cystectomy for T1 bladder cancer - Slide Presentation
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Presented by David P. Wood, MD at the VI Maratona Urológica do Rio de Janeiro - August 14 - 15, 2009.
Login to read more...

Maratona Urológica 2009 - Pathology of Bladder Cancer - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - Currently recommended classification of urothelial cancer is based on the WHO 2004 consensus conference.
Login to read more...

Intravesical Bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: Effects of concurrent statin therapy - Abstract
Tuesday, 18 August 2009
Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St Louis, MO 63110, USA.
read more

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer - Abstract
Tuesday, 18 August 2009
Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
read more

Maratona Urológica 2009 - What is the best method to evaluate invasive bladder cancer? - Session Highlights
Tuesday, 18 August 2009
RIO DE JANEIRO, BRAZIL (UroToday.com) - The optimal method of evaluating bladder cancer is with MRI rather than CT due to the intrinsically higher contrast to noise ratio and multiplaner imaging.
Login to read more...

Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: A population-based matched analysist - Abstract
Monday, 17 August 2009
Department of Urology, Vita-Salute San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada.
read more

Urologic oncologist Kellogg Parsons, MD, recognized as health leader
Friday, 14 August 2009
SAN DIEGO, CA, USA (News Release) - August 13, 2009
read more

Beyond the Abstract - Multiple adverse histological features increase the odds of under staging T1 bladder cancer, by Alon Z. Weizer, MD
Thursday, 13 August 2009
BERKELEY, CA (UroToday.com) - Patients with T1 bladder cancer have an uncertain natural history.
Login to read more...

Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer - Abstract
Wednesday, 12 August 2009
The Prostate Centre at Vancouver General Hospital and Departments of Urologic Sciences and Earth and Ocean Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
read more

Cell adhesion to fibronectin induces mitomycin C resistance in bladder cancer cells - Abstract
Tuesday, 11 August 2009
Department of Urology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, and Department of Histology & Embryology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
read more

Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins - Abstract
Tuesday, 11 August 2009
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina
read more

Generation of a concise gene panel for outcome prediction in urinary bladder cancer - Abstract
Friday, 07 August 2009
Departments of Pathology, Preventive Medicine, and Urology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles.
read more

A multidisciplinary approach to the management of urologic malignancies: Does it influence diagnostic and treatment decisions? - Abstract
Thursday, 06 August 2009
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
read more

Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder - Abstract
Thursday, 06 August 2009
Department of Urology, Shanxi Cancer Hospital, Taiyuan 030013, China.
read more

Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition - Abstract
Thursday, 06 August 2009
The National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
read more

Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy - Abstract
Thursday, 06 August 2009
New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA.
read more

Penile metastasis of urothelial carcinoma diagnosed by fine-needle aspiration - Abstract
Thursday, 06 August 2009
Department of Pathology, Escola Paulista de Medicina, UNIFESP (Federal University of São Paulo).
read more

Variation in prostate stem cell antigen gene raises bladder cancer risk
Wednesday, 05 August 2009
HOUSTON, TX, USA (News Release) - August 2, 2009
read more

Complications and mortality after radical cystectomy for bladder transitional cell cancer - Abstract
Wednesday, 05 August 2009
Department of Oncological and Surgical Sciences, Urology Clinic, University of Padua, Padua, Italy.
read more

p53 predictive value for pT1-2 N0 disease at radical cystectomy - Abstract
Wednesday, 05 August 2009
Department of Urology, University of Texas Southwestern Medical Center, Dallas.
read more

Hypersensitivity pneumonitis following intravesical bacille Calmette-Guérin immunotherapy for superficial bladder cancer - Abstract
Tuesday, 04 August 2009
Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea.
read more

Repeat transurethral resection for non-muscle invasive bladder cancer - Abstract
Tuesday, 04 August 2009
Department of Urology, Cancer Hospital, Fudan University, Shanghai 200032, China.
read more

Prediction of muscle-invasive bladder cancer using urinary proteomics - Abstract
Monday, 03 August 2009
Mosaiques Diagnostics and Therapeutics, Hannover, Germany.
read more

The feasibility of computational modelling technique to detect the bladder cancer - Abstract
Monday, 03 August 2009
Medical Physics Department, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
read more

Current trends in the management of bladder cancer - Abstract
Monday, 03 August 2009
Glickman Urological and Kidney Institute, The Cleveland Clinic, Ohio 44195, USA.
read more

Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation - Abstract
Friday, 31 July 2009
Departments of Urology and Radiology, Osaka Medical College, Takatsuki, Osaka.
read more

Capsaicin mediates cell death in bladder cancer T24 cells through reactive oxygen species production and mitochondrial depolarization - Abstract
Friday, 31 July 2009
Department of Urology, Zhongnan Hospital, Wuhan University, Wuhan, China.
read more

Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer - Abstract
Friday, 31 July 2009
Division of Urology, McGill University Health Center, Montreal, Quebec, Canada.
read more

The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder - Abstract
Friday, 31 July 2009
Department of Urology, Yonsei University College of Medicine, Seoul, Korea.
read more

The clinical study for reducing bladder cancer recurrence after surgical treatment for renal pelvic carcinoma - Abstract
Friday, 31 July 2009
Department of Urology, the First Hospital of China Medical University, Shenyang 110001, China.
read more

Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation - Abstract
Thursday, 30 July 2009
Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
read more

Potential new urinary markers in the early detection of bladder cancer - Abstract
Thursday, 30 July 2009
Departments of Urology, Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.
read more

Patient awareness of smoking as a risk factor for bladder cancer - Abstract
Thursday, 30 July 2009
1st Department of Urology, Athens Medical School, Agiou Thoma 17, 11527, Athens, Greece.
read more

Micronutrient intake and risk of urothelial carcinoma in a prospective Danish cohort - Abstract
Wednesday, 29 July 2009
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
read more

Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy - Abstract
Wednesday, 29 July 2009
Department of Surgical Oncology, Division of Urology, University of Toronto, UHN, Toronto, Ontario, Canada.
read more

The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma - Abstract
Wednesday, 29 July 2009
University of Toronto, Department of Pathology, University Health Network, Toronto, Canada.
read more

Defects in muscarinic receptor cell signaling in bladder urothelial cancer cell lines - Abstract
Tuesday, 28 July 2009
Division of Urology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
read more

Candidate quality of care indicators for localized bladder cancer - Abstract
Tuesday, 28 July 2009
Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA.
read more

EAU guidelines on non-muscle-carcinoma of the bladder - Abstract
Tuesday, 28 July 2009
Servicio de Urología, Hospital General de Enseñanza, Primera Facultad de Medicina, Universidad de Carlos, Praga, República Checa.
read more

How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer? - Abstract
Monday, 27 July 2009
Department of Urology, Academic Medical Center Amsterdam, The Netherlands.
read more

Robotic cystectomy and the Internet: Separating fact from fiction - Abstract
Monday, 27 July 2009
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
read more

Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy - Abstract
Monday, 27 July 2009
Urology Department, Krankenhaus der Elisabethinen, Linz, Austria.
read more

Tobacco use and bladder cancer patterns in three western European countries - Abstract
Friday, 24 July 2009
Harvard School of Public Health, Division of Public Health Practice, Boston, MA, USA.
read more

Survival disparities among African American women with invasive bladder cancer in Florida - Abstract
Friday, 24 July 2009
Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, Miami, Florida.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts